Chinese Pharmaceutical Industry Competes for Vaccine Market Share
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to start selling their own version of drugs previously available only through global pharmaceutical giants Pfizer,…
CONTINUE READINGTamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC)…
Vaccine Market Valued at $93 Billion by 2026
A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by…
GlaxoSmithKline Partners with Viome to Develop New Vaccines
Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington…
Medical Errors Kill Five People Per Minute, 2.6 Million People Every Year
A new report published by the World Health Organization (WHO) estimates that 2.6 million people die annually in low-and middle-income…
CDC Urged to Be Truthful About Its Corporate Financial Ties
Public interest nonprofit organizations U.S. Right to Know and Public Citizen have petitioned the Centers for Disease Control and Prevention…
Medical “Experts” Were Wrong About the Safety of Opioids
Story Highlights Addiction to and death from prescription painkillers is now a public health crisis in the United States. In…